ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.
Chaluts D, Dullea JT, Ali M, Vasan V, Devarajan A, Rutland JW, Gill CM, Ellis E, Kinoshita Y, McBride RB, Bederson J, Donovan M, Sebra R, Umphlett M, Shrivastava RK.
Chaluts D, et al. Among authors: devarajan a.
J Cancer Res Clin Oncol. 2023 Jul;149(8):5165-5172. doi: 10.1007/s00432-022-04442-y. Epub 2022 Nov 9.
J Cancer Res Clin Oncol. 2023.
PMID: 36348021